Aclaris Therapeutics, Inc. (ACRS)

USD 1.13

(-0.88%)

Long Term Debt Summary of Aclaris Therapeutics, Inc.

  • Aclaris Therapeutics, Inc.'s latest annual long term debt in 2023 was 3.07 Million USD , up 95.8% from previous year.
  • Aclaris Therapeutics, Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Aclaris Therapeutics, Inc. reported annual long term debt of 1.57 Million USD in 2022, down -27.72% from previous year.
  • Aclaris Therapeutics, Inc. reported annual long term debt of 2.17 Million USD in 2021, down -79.61% from previous year.
  • Aclaris Therapeutics, Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Aclaris Therapeutics, Inc. reported quarterly long term debt of 1.83 Million USD for 2023 Q3, down -3.63% from previous quarter.

Annual Long Term Debt Chart of Aclaris Therapeutics, Inc. (2023 - 2013)

Historical Annual Long Term Debt of Aclaris Therapeutics, Inc. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 3.07 Million USD 95.8%
2022 1.57 Million USD -27.72%
2021 2.17 Million USD -79.61%
2020 10.65 Million USD 198.49%
2019 3.56 Million USD -88.07%
2018 29.91 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Long Term Debt Comparison of Aclaris Therapeutics, Inc.

Name Long Term Debt Long Term Debt Difference
Applied DNA Sciences, Inc. 739.16 Thousand USD -315.876%
Aspira Women's Health Inc. 1.43 Million USD -114.965%
Biodesix, Inc. 35.22 Million USD 91.273%
BioNexus Gene Lab Corp. 98.76 Thousand USD -3012.502%
bioAffinity Technologies, Inc. 1.11 Million USD -174.84%
bioAffinity Technologies, Inc. 1.11 Million USD -174.84%
Bionano Genomics, Inc. 7.17 Million USD 57.157%
CareDx, Inc 28.27 Million USD 89.129%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD 78.349%
DarioHealth Corp. 24.59 Million USD 87.499%
Exact Sciences Corporation 2.47 Billion USD 99.876%
Fulgent Genetics, Inc. 10.11 Million USD 69.597%
Guardant Health, Inc. 1.13 Billion USD 99.73%
ICON Public Limited Company 3.66 Billion USD 99.916%
IDEXX Laboratories, Inc. 622.88 Million USD 99.506%
Illumina, Inc. 1.48 Billion USD 99.794%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -3679.942%
iSpecimen Inc. 29.13 Thousand USD -10452.695%
Standard BioTools Inc. 3.98 Million USD 22.822%
MDxHealth SA 35.56 Million USD 91.356%
23andMe Holding Co. 67.84 Million USD 95.469%
Medpace Holdings, Inc. 142.12 Million USD 97.837%
Myriad Genetics, Inc. 130.9 Million USD 97.652%
Mainz Biomed B.V. 2.19 Million USD -39.989%
ENDRA Life Sciences Inc. 192.06 Thousand USD -1500.525%
NeoGenomics, Inc. 606.06 Million USD 99.493%
Neogen Corporation 888.39 Million USD 99.654%
Inotiv, Inc. 399.4 Million USD 99.23%
Natera, Inc. 282.94 Million USD 98.914%
OpGen, Inc. 2.02 Million USD -52.057%
OPKO Health, Inc. 222.03 Million USD 98.616%
Psychemedics Corporation 945 Thousand USD -225.291%
Prenetics Global Limited 867.21 Thousand USD -254.468%
Prenetics Global Limited 867.21 Thousand USD -254.468%
Precipio, Inc. 106 Thousand USD -2800.0%
Personalis, Inc. 1.23 Million USD -149.109%
RadNet, Inc. 812.06 Million USD 99.621%
Sera Prognostics, Inc. 840 Thousand USD -265.952%
Sotera Health Company 2.22 Billion USD 99.862%
Neuronetics, Inc. 59.28 Million USD 94.815%
Star Equity Holdings, Inc. 1.14 Million USD -168.472%
Star Equity Holdings, Inc. 1.14 Million USD -168.472%
Trinity Biotech plc 54.65 Million USD 94.375%
T2 Biosystems, Inc. 6.59 Million USD 53.41%
Twist Bioscience Corporation 79.17 Million USD 96.117%
Exagen Inc. 19.23 Million USD 84.015%